Exploring We Are Precision Biosciences
Let's dive into the details surrounding We Are Precision Biosciences.
- Michael Dombeck, VP, Business Development Durham, NC (Private)
- Michael Dombeck, VP, Business Development Durham, NC (Private) At
- Matt Kane, CEO Durham, NC (Private)
- Cindy Atwell, VP, Business Development Durham, NC (NASDAQ: DTIL)
- Matt Kane, CEO Durham, NC (Private)
In-Depth Information on We Are Precision Biosciences
Precision BioSciences This short video shares the story of the origins of ARCUS® is a proprietary genome editing technology discovered and developed by scientists at Michael Dombeck, VP, Business Development Durham, NC (Private)
Michael Dombeck, SVP, Corporate Development Durham, NC (NASDAQ: DTIL)
That wraps up our extensive overview of We Are Precision Biosciences.
